G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207:374.e1–374.e6. [PubMed] [Full Text] ^ 13. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian
GM, Haddow JE, Neveux LM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collab-orative study. Genet Med 2012;14:296–305.[PubMed] [Full Text] ^ 14. Pergament E, Cuckle H, Zimmermann B, Banjevic
M, Sigurjonsson S, Ryan A, et al. Single-nucleotide polymorphism-based noninvasive prenatal screen-ing in a high-risk and low-risk cohort. Obstet Gynecol 2014;124:210–8. [PubMed] [Obstetrics & Gynecology] ^ 15. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A.
Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evalua-tion for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:319.e1–319.e9. [PubMed] [Full Text] ^ 16. Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies. Ultrasound Obstet Gynecol 2015;45:530–8. [PubMed] [Full Text] ^ 17. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini
AC, Brar H, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;372:1589–97. [PubMed] [Full Text] ^ 18. Bianchi DW, Parsa S, Bhatt S, Halks-Miller M, Kurtzman
K, Sehnert AJ, et al. Fetal sex chromosome testing by mater-nal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol 2015;125:375–82. [PubMed] [Obstetrics & Gynecology] ^ 19. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides
KH. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation: relation to maternal and fetal
characteristics. Ultrasound Obstet Gynecol 2013;41:26–32. [PubMed] [Full Text] ^
20. Willems PJ, Dierickx H, Vandenakker E, Bekedam D,
Segers N, Deboulle K, et al. The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands. Facts Views Vis Obgyn 2014;6:7–12. [PubMed] [Full Text] ^ 21. Alamillo CM, Krantz D, Evans M, Fiddler M, Pergament E.
Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experi-ence from a single center. Prenat Diagn 2013;33:251–6.[PubMed] ^ 22. Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K,
Skotko BG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395–8. [PubMed] [Full Text] ^ 23. Norton ME, Jelliffe-Pawlowski LL, Currier RJ. Chrom-osome abnormalities detected by current prenatal screen-ing and noninvasive prenatal testing. Obstet Gynecol 2014;124:979–86. [PubMed] [Obstetrics & Gynecology] ^ 24. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava
RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92:167–76. [PubMed] [Full Text] ^ 25. Wapner RJ, Babiarz JE, Levy B, Stosic M, Zimmermann
B, Sigurjonsson S, et al. Expanding the scope of nonin-vasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2015;212:332.e1–332.e9. [PubMed] [Full Text] ^ 26. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow
JE, Ehrich M, van den Boom D, et al. DNA sequencing of maternal plasma to identify Down syndrome and other tri-somies in multiple gestations. Prenat Diagn 2012;32:730–4. [PubMed] [Full Text] ^ 27. Huang X, Zheng J, Chen M, Zhao Y, Zhang C, Liu L, et al.
Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 2014;34:335–40. [PubMed] [Full Text] ^ 28. Curnow KJ, Wilkins-Haug L, Ryan A, Kirkizlar E, Stosic M,
Hall MP, et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol 2015;212:79.e1–79.e9. [PubMed] [Full Text] ^ 29. Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati
C, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014;16:620–4. [PubMed] [Full Text] ^ 30. Hall AL, Drendel HM, Verbrugge JL, Reese AM, Schumacher
KL, Griffith CB, et al. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genet Med 2013;15:729–32. [PubMed] [Full Text] ^
e36 Committee Opinion Cell-free DNA Screening for Fetal Aneuploidy OBSTETRICS & GYNECOLOGY
国际母胎医学会遗传学专业委员会(Committee on Genetics, Society for Maternal–Fetal Medicine)针对利用游离胎儿DNA筛查非整倍体(cell-free DNA screening for fetal aneuploidy)的建议。
31. Osborne CM, Hardisty E, Devers P, Kaiser-Rogers K,
Hayden MA, Goodnight W, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609–11. [PubMed] [Full Text]